REGISTRAT-MAPI | MAPI EPI | MAPI INSTITUTE | MAPI RESEARCH TRUST | PROSANOS | JNBD | MAPI VALUES | 


REGISTRAT- MAPI is a Global Late Phase CRO with a strong expertise in Peri-Approval studies.

With a presence in both the United States and Europe, our organization has the necessary expertise to conduct large International studies and achieve a successful drug life cycle.

 

Specialized in:

Phase IIIb-IV Studies

Pharmaco-epidemiological Studies

Risk Management Programs

Disease and Product Registries

 

We provide a complete Spectrum of Integrated Late Phase Services :

 

Strategic Consulting Services

Risk Evaluation and Medical Strategies

Optimal Study Design

Multidisciplinary Excellence in Patient Reported Outcomes

Multi-country Regulatory Management & Ethical Submissions

Accurate Implementation Process & Project Management

In Fine PHARMA : network of 2000 pharmacists in France

Remote and on-site monitoring

Tailored integrated EDC & Call Centre solutions

Data Management Services

Late Phase oriented Statistical Methods

Medical Writing, Publications

Integrated Technologies

 

 

You can also find us at:


27 rue de la Villette

69003 Lyon

FRANCE

Tel:  +33 (0)472 35 66 66

Fax: +33 (0)472 13 59 62





Area(s) of Practice
Phase IIIb-IV Studies
Pharmaco-epidemiological Studies
Risk Management Programs
Disease and Product Registries
Office Location(s)
Frankfurt, Germany
Lexington, USA
Lyon, France
London, UK
Paris, France
Philadelphia, USA
Rome, Italy
Utrecht, Netherlands
Established
MAPI founded in 1990
REGISTRAT founded in 1995
The Joint venture REGISTRAT MAPI was founded in 2009
Director(s)
Hubert MECHIN (EU)
Stephen WEBB (North America)
Contact
cmaki@registrat.com
fdistler@mapigroup.com
vdekou@mapigroup.com

Mapi Group Mapi Phimap Mapi Research Institute Mapi Research Trust Mapi Values JNBD ProSanos Mapi EPI